by BENJAMIN WERNER CHRISTENSEN, translated by daniel pedersen
The pipeline has failed, sales of migraine drug Vypeti, which cost billions to acquire, have failed, and so, it seems, has the firm’s ability to make money. Still, the pharmaceutical company’s new CCO, Jacob Tolstrup, is optimistic on Lundbeck’s behalf.
”2022 will be a growth year for Lundbeck in all regions,” says Tolstrup, executive vice president and chief commercial officer of commercial operations at Lundbeck.
Wouldn’t this follow a 2021 that has been pretty bad?
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Long wait for IVDR implementation is over, putting an end to pandemic "wild west"
After prolonged debates on potential bottlenecking and supply issues, the EU’s long-awaited In Vitro Diagnostic Medical Devices Regulation comes into force on May 26.
GN purchase story is very speculative, says analyst
Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.
Bavarian Nordic upgrades guidance following vaccine contract
Bavarian has been the center of attention in recent days due to its monkeypox vaccine, and the company has now secured a vaccine contract with another undisclosed country. Consequently, Bavarian has raised its expectations for the full year.
Novo Nordisk invests additional millions of dollars in new manufacturing facilities
Novo Nordisk’s DKK 17bn (USD 2.4bn) investment into upgrading and building new facilities in Kalundborg last year has now been followed by a DKK 1bn (USD 143.8m) investment in the same location.
US to start using Bavarian vaccine stockpile
In an attempt to contain a monkeypox outbreak, US authorities will start offering certain people Bavarian Nordic-developed Jynneos vaccinations against the infectious disease.
Account Manager 
Clinical Trial Administrator 
Communications Consultant 
Production Director 
Clinical Trial Manager 
Senior Chemical Safety Advisor 
Biomarker Operations Lead 
Senior IT Network Engineer 
Clinical Trial Manager for development of in vitro diagnostics 
Nordic Medical Affairs Manager 
2 Sales Representatives and Product Specialists 
(Senior) Drug Substance Specialist 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Industrial Designer- Design Engineer 
Senior Manager, Clinical Trial Budget 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Key Account Manager, Europe and Asia 
Director Global Engineering